Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Association Between Vasopressin and Adverse Kidney Outcomes in Children and Young Adults Requiring Vasopressors on Continuous Renal Replacement Therapy.
Hasson DC, Gist KM, Seo J, Stenson EK, Kessel A, Haga T, LaFever S, Santiago MJ, Barhight M, Selewski D, Ricci Z, Ollberding NJ, Stanski NL; Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative. Hasson DC, et al. Crit Care Explor. 2024 Sep 20;6(10):e1156. doi: 10.1097/CCE.0000000000001156. eCollection 2024 Oct. Crit Care Explor. 2024. PMID: 39318499 Free PMC article.
Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).
Stanski NL, Gist KM, Hasson D, Stenson EK, Seo J, Ollberding NJ, Muff-Luett M, Cortina G, Alobaidi R, See E, Kaddourah A, Fuhrman DY; Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Investigators. Stanski NL, et al. Among authors: muff luett m. Crit Care Med. 2024 Nov 1;52(11):1686-1699. doi: 10.1097/CCM.0000000000006405. Epub 2024 Sep 11. Crit Care Med. 2024. PMID: 39258974
Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study.
Menon S, Starr MC, Zang H, Collins M, Damian MA, Fuhrman D, Krallman K, Soranno DE, Webb TN, Slagle C, Joseph C, Martin SD, Mohamed T, Beebe ME, Ricci Z, Ollberding N, Selewski D, Gist KM; WE-ROCK investigators. Menon S, et al. Pediatr Nephrol. 2025 Jan;40(1):253-264. doi: 10.1007/s00467-024-06438-x. Epub 2024 Aug 20. Pediatr Nephrol. 2025. PMID: 39164502
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials.
Dixon BP, Kavanagh D, Aris ADM, Adams B, Kang HG, Wang E, Garlo K, Ogawa M, Amancha P, Chakravarty S, Heyne N, Kim SH, Cataland S, Yoon SS, Miyakawa Y, Luque Y, Muff-Luett M, Tanaka K, Greenbaum LA. Dixon BP, et al. Among authors: muff luett m. Kidney Med. 2024 Jun 14;6(8):100855. doi: 10.1016/j.xkme.2024.100855. eCollection 2024 Aug. Kidney Med. 2024. PMID: 39105067 Free PMC article.
Factors associated with successful liberation from continuous renal replacement therapy in children and young adults: analysis of the worldwide exploration of renal replacement outcomes collaborative in Kidney Disease Registry.
Stenson EK, Alhamoud I, Alobaidi R, Bottari G, Fernandez S, Fuhrman DY, Guzzi F, Haga T, Kaddourah A, Marinari E, Mohamed T, Morgan C, Mottes T, Neumayr T, Ollberding NJ, Raggi V, Ricci Z, See E, Stanski NL, Zang H, Zangla E, Gist KM; WE-ROCK Investigators. Stenson EK, et al. Intensive Care Med. 2024 Jun;50(6):861-872. doi: 10.1007/s00134-024-07336-4. Epub 2024 Mar 4. Intensive Care Med. 2024. PMID: 38436726 Free PMC article.
Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy.
Fuhrman DY, Stenson EK, Alhamoud I, Alobaidi R, Bottari G, Fernandez S, Guzzi F, Haga T, Kaddourah A, Marinari E, Mohamed TH, Morgan CJ, Mottes T, Neumayr TM, Ollberding NJ, Raggi V, Ricci Z, See E, Stanski NL, Zang H, Zangla E, Gist KM; WE-ROCK Investigators. Fuhrman DY, et al. JAMA Netw Open. 2024 Feb 5;7(2):e240243. doi: 10.1001/jamanetworkopen.2024.0243. JAMA Netw Open. 2024. PMID: 38393726 Free PMC article.
Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.
Starr MC, Gist KM, Zang H, Ollberding NJ, Balani S, Cappoli A, Ciccia E, Joseph C, Kakajiwala A, Kessel A, Muff-Luett M, Santiago Lozano MJ, Pinto M, Reynaud S, Solomon S, Slagle C, Srivastava R, Shih WV, Webb T, Menon S; Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative. Starr MC, et al. Among authors: muff luett m. Am J Kidney Dis. 2024 Oct;84(4):406-415.e1. doi: 10.1053/j.ajkd.2023.12.017. Epub 2024 Feb 15. Am J Kidney Dis. 2024. PMID: 38364956 Free PMC article.
Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults.
Gist KM, Menon S, Anton-Martin P, Bigelow AM, Cortina G, Deep A, De la Mata-Navazo S, Gelbart B, Gorga S, Guzzo I, Mah KE, Ollberding NJ, Shin HS, Thadani S, Uber A, Zang H, Zappitelli M, Selewski DT; WE-ROCK Investigators. Gist KM, et al. JAMA Netw Open. 2024 Jan 2;7(1):e2349871. doi: 10.1001/jamanetworkopen.2023.49871. JAMA Netw Open. 2024. PMID: 38165673 Free PMC article.
Ethical Concerns for Amnioinfusions-Reply.
Soffer OD, Mauch TJ, Muff-Luett MA. Soffer OD, et al. Among authors: muff luett ma. JAMA. 2023 Oct 17;330(15):1493-1494. doi: 10.1001/jama.2023.15930. JAMA. 2023. PMID: 37847275 No abstract available.
Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).
Menon S, Krallman KA, Arikan AA, Fuhrman DY, Gorga SM, Mottes T, Ollberding N, Ricci Z, Stanski NL, Selewski DT, Soranno DE, Zappitelli M, Zang H, Gist KM; WE-ROCK Investigators. Menon S, et al. Kidney Int Rep. 2023 Jun 5;8(8):1542-1552. doi: 10.1016/j.ekir.2023.05.026. eCollection 2023 Aug. Kidney Int Rep. 2023. PMID: 37547524 Free PMC article.
22 results